Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ypsomed Holding AGYPHDF 94 Earnings per Share (Diluted) is $20.56 as of Mar. 2026. GuruFocus rates YPHDF with a GF Score™ of 94/100 and a GF Value™ of $461.36 (Fairly Valued). The stock has 5 warning signs investors should review. Among 658 Medical Devices & Instruments companies, Ypsomed Holding AG ranks better than 92.71% on this metric.
Ypsomed Holding AG's EPS (Basic) for the
six
months ended in Mar. 2026 was $7.77.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $20.57.
During the past 12 months, Ypsomed Holding AG's average EPS without NRIGrowth Rate was 154.30% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 62.20% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 106.70% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 11.90% per year.
During the past 13 years, Ypsomed Holding AG's highest 3-Year average EPS without NRI Growth Rate was 191.80% per year. The lowest was -89.90% per year. And the median was 25.85% per year.
Ypsomed Holding AG (OTCPK:YPHDF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Ypsomed Holding AG Earnings per Share (Diluted) Related Terms
Ypsomed Holding AG Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Ypsomed Holding AG's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ypsomed Holding AG Earnings per Share (Diluted) Chart
YPHDF vs ISRG, BDX, MDLN: Earnings per Share (Diluted) Comparison
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's PE Ratio distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's PE Ratio falls into.
Ypsomed Holding AG Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Ypsomed Holding AG's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2026 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $20.56
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $20.56 mean?
Ypsomed Holding AG (YPHDF) has a Earnings per Share (Diluted) of $20.56 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Ypsomed Holding AG and its competitors. According to the industry distribution chart, Ypsomed Holding AG ranks #48 out of 658 companies in the Medical Devices & Instruments industry, placing it in the top 7.3%.
Is Ypsomed Holding AG's Earnings per Share (Diluted) too high?
Ypsomed Holding AG's current Earnings per Share (Diluted) is $20.56. The Medical Devices & Instruments industry median Earnings per Share (Diluted) is 8.05. Ypsomed Holding AG's value of $20.56 is 155.4% above this industry median. Based on the distribution chart, Ypsomed Holding AG ranks #48 out of 658 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ypsomed Holding AG has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Earnings per Share (Diluted) compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #48 out of 658 companies for Earnings per Share (Diluted). This places Ypsomed Holding AG in the top 7% of its industry — outperforming the majority of peers. The industry median Earnings per Share (Diluted) is 8.05. Ypsomed Holding AG's value of $20.56 is 155.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Medical Devices & Instruments company?
The median Earnings per Share (Diluted) among Medical Devices & Instruments companies is 8.05, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ypsomed Holding AG's current Earnings per Share (Diluted) of $20.56 is 155.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Ypsomed Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Earnings per Share (Diluted) is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current Earnings per Share (Diluted) is $20.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (YPHDF) is currently considered Fairly Valued. The stock's GF Value™ is $461.36, compared to a current price of $476.49 — trading 3.3% above its estimated fair value. The current Earnings per Share (Diluted) is $20.56 and 155.4% above the Medical Devices & Instruments industry median of 8.05. Ypsomed Holding AG's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Ypsomed Holding AG (YPHDF), the current Earnings per Share (Diluted) is $20.56 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (YPHDF) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be overvalued.
The current stock price of $476.49 is trading 3.3% above its estimated GF Value™ of $461.36.
GuruFocus considers Ypsomed Holding AG to be Fairly Valued.
Key valuation signals for YPHDF:
Earnings per Share (Diluted): $20.56
GF Value™: $461.36 vs. price of $476.49 (3.3% above fair value)
Industry Position: 155.4% above the Medical Devices & Instruments median (#48 of 658)
No single metric tells the full story. See the YPHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
94GF Score
Get the complete analysis for YPHDF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YPHDF has been successfully added to your 
